KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Operating Expenses (2018 - 2025)

ClearPoint Neuro's Operating Expenses history spans 13 years, with the latest figure at $7.0 million for Q3 2025.

  • For Q3 2025, Operating Expenses rose 9.01% year-over-year to $7.0 million; the TTM value through Sep 2025 reached $28.3 million, up 22.3%, while the annual FY2024 figure was $24.4 million, 3.94% up from the prior year.
  • Operating Expenses for Q3 2025 was $7.0 million at ClearPoint Neuro, down from $7.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $7.5 million in Q1 2025 and bottomed at $3.2 million in Q1 2021.
  • The 5-year median for Operating Expenses is $5.4 million (2023), against an average of $5.6 million.
  • The largest annual shift saw Operating Expenses skyrocketed 99.97% in 2021 before it fell 21.11% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $4.9 million in 2021, then dropped by 21.11% to $3.9 million in 2022, then soared by 37.71% to $5.4 million in 2023, then rose by 22.95% to $6.6 million in 2024, then increased by 6.56% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Operating Expenses are $7.0 million (Q3 2025), $7.2 million (Q2 2025), and $7.5 million (Q1 2025).